BERNS PAUL L

CIK 000120276912 companiesWATERTOWN, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001202769

Recent Transactions

50 trades

Award
Neumora Therapeutics, Inc.$NMRA
Stock Option (Right to Buy)
2026-01-08+1,650,000→ 1,650,000 total
Award
Metsera, Inc.$MTSR
Restricted Stock Unit
2025-11-13+4,031→ 4,031 total
Disposition to Issuer
Metsera, Inc.$MTSR
Common Stock
2025-11-13−7,523,682→ 0 total
Disposition to Issuer
Metsera, Inc.$MTSR
Stock Option (right to buy)
2025-11-13−24,188→ 0 total
Disposition to Issuer
Metsera, Inc.$MTSR
Common Stock
2025-11-13−4,031→ 0 total
Disposition to Issuer
Metsera, Inc.$MTSR
Stock Option (right to buy)
2025-11-13−223,430→ 0 total
Disposition to Issuer
Metsera, Inc.$MTSR
Common Stock
2025-11-13−957,559→ 0 total
Disposition to Issuer
Metsera, Inc.$MTSR
Common Stock
2025-11-13−8,313,680→ 0 total
Award
Neumora Therapeutics, Inc.$NMRA
Stock Option (Right to Buy)
2025-05-28+955,864→ 955,864 total
Award
Neumora Therapeutics, Inc.$NMRA
Stock Option (Right to Buy)
2025-05-28+342,500→ 342,500 total
Disposition to Issuer
Neumora Therapeutics, Inc.$NMRA
Stock Option (Right to Buy)
2025-05-28−497,049→ 0 total
Disposition to Issuer
Neumora Therapeutics, Inc.$NMRA
Stock Option (Right to Buy)
2025-05-28−955,864→ 0 total
Disposition to Issuer
Neumora Therapeutics, Inc.$NMRA
Stock Option (Right to Buy)
2025-05-28−342,500→ 0 total
Award
Neumora Therapeutics, Inc.$NMRA
Stock Option (Right to Buy)
2025-05-28+2,000,000→ 2,000,000 total
Disposition to Issuer
Neumora Therapeutics, Inc.$NMRA
Stock Option (Right to Buy)
2025-05-28−2,000,000→ 0 total
Award
Neumora Therapeutics, Inc.$NMRA
Stock Option (Right to Buy)
2025-05-28+497,049→ 497,049 total
Award
Metsera, Inc.$MTSR
Stock Option (Right to Buy)
2025-05-20+24,188→ 24,188 total
Sale
Neumora Therapeutics, Inc.$NMRA
Common Stock
2025-02-18$1.69/sh−13,871→ 7,405,004 total
Disposition to Issuer
Neumora Therapeutics, Inc.$NMRA
Stock Option (Right to Buy)
2025-02-13−342,500→ 0 total
Award
Neumora Therapeutics, Inc.$NMRA
Stock Option (Right to Buy)
2025-02-13+497,049→ 497,049 total
Award
Neumora Therapeutics, Inc.$NMRA
Stock Option (Right to Buy)
2025-02-13+2,000,000→ 2,000,000 total
Award
Neumora Therapeutics, Inc.$NMRA
Stock Option (Right to Buy)
2025-02-13+955,864→ 955,864 total
Disposition to Issuer
Neumora Therapeutics, Inc.$NMRA
Stock Option (Right to Buy)
2025-02-13−497,049→ 0 total
Disposition to Issuer
Neumora Therapeutics, Inc.$NMRA
Stock Option (Right to Buy)
2025-02-13−955,864→ 0 total
Award
Neumora Therapeutics, Inc.$NMRA
Stock Option (Right to Buy)
2025-02-13+342,500→ 342,500 total
Conversion
Metsera, Inc.$MTSR
Series B Convertible Preferred Stock
2025-02-03−2,678,571→ 0 total
Purchase
Metsera, Inc.$MTSR
Common Stock
2025-02-03$18.00/sh+789,998→ 8,313,680 total
Conversion
Metsera, Inc.$MTSR
Common Stock
2025-02-03+7,523,682→ 7,523,682 total
Conversion
Metsera, Inc.$MTSR
Series A Convertible Preferred Stock
2025-02-03−15,000,000→ 0 total
Gift
Neumora Therapeutics, Inc.$NMRA
Common Stock
2024-12-27−133,097→ 7,418,875 total
Gift
Neumora Therapeutics, Inc.$NMRA
Common Stock
2024-12-27−133,097→ 7,685,069 total
Gift
Neumora Therapeutics, Inc.$NMRA
Common Stock
2024-12-27−133,097→ 7,551,972 total
Award
Unity Biotechnology, Inc.
Stock Option (Right to Buy)
2024-06-21+10,000→ 10,000 total
Award
Neumora Therapeutics, Inc.$NMRA
Stock Option (Right to Buy)
2024-02-14+342,500→ 342,500 total
Award
Neumora Therapeutics, Inc.$NMRA
Common Stock
2024-02-14+171,250→ 7,818,166 total
Disposition to Issuer
EQRx, Inc.
Earn-out Shares
2023-11-09−86,344→ 0 total
Disposition to Issuer
EQRx, Inc.
Common Stock
2023-11-09−627,000→ 0 total
Disposition to Issuer
EQRx, Inc.
Stock Option (Right to Buy)
2023-11-09−101,010→ 0 total
Award
Unity Biotechnology, Inc.
Stock Option (Right to Buy)
2023-06-23+6,000→ 6,000 total
Award
EQRx, Inc.
Earn-out Shares
2023-01-01+453→ 86,344 total
Award
EQRx, Inc.
Stock Option (Right to Buy)
2022-09-30+101,010→ 101,010 total
Award
Unity Biotechnology, Inc.
Stock Option (Right to Buy)
2022-06-24+25,000→ 25,000 total
Award
EQRx, Inc.
Earn-out Shares
2021-12-17+85,891→ 85,891 total
Award
EQRx, Inc.
Common Stock
2021-12-17+627,000→ 627,000 total
Sale
Jazz Pharmaceuticals plc$JAZZ
Ordinary Shares
2021-08-05$154.00/sh−1,450→ 8,290 total
Award
Unity Biotechnology, Inc.
Stock Option (Right to Buy)
2021-06-24+25,000→ 25,000 total
Sale
Jazz Pharmaceuticals plc$JAZZ
Ordinary Shares
2020-11-04$150.90/sh−3,825→ 9,740 total
Sale
Jazz Pharmaceuticals plc$JAZZ
Ordinary Shares
2020-11-04$149.28/sh−400→ 13,565 total
Sale
Jazz Pharmaceuticals plc$JAZZ
Ordinary Shares
2020-11-04$147.44/sh−466→ 13,965 total
Exercise/Conversion
Jazz Pharmaceuticals plc$JAZZ
Phantom Stock
2020-11-02−4,691→ 0 total

Companies

Recent Filings

Address

C/O NEUMORA THERAPEUTICS, INC. 260 ARSENAL WAY, SUITE 1

WATERTOWN, MA, 02472

View on SEC.gov